Preclinical studies are essential for ensuring that a nanotechnology-based intervention is safe and effective before proceeding to human trials. They help identify potential adverse effects and optimal dosing regimens. Additionally, preclinical data can support regulatory submissions to agencies like the FDA or EMA, which are critical for obtaining approval to begin clinical trials.
